Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its ...

The system offers zero-exchange delivery with a unique atraumatic design to reduce steps and eliminate rewiring during access ...

Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.

Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has received 510 (k) clearance from ...

US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried out using its device ...

BALTIMORE, October 24, 2025--(BUSINESS WIRE)--Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today ...

BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, a pioneer in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study, demonstrating the transformative ...

Transseptal Solutions, developer of a new steerable sheath with a novel approach of transseptal puncture and left atrial navigation to treat multiple clinical indications, has received its first ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and ...

Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation to introduce various cardiovascular catheters ...

Physicians with limited experience closing the left atrial appendage (LAA) with the Watchman device (Boston Scientific) in patients with atrial fibrillation do not appear to have worse clinical ...